首页|期刊导航|中国医疗设备|基于蒙特卡洛算法下宫颈癌放疗计划退行性迭代的研究

基于蒙特卡洛算法下宫颈癌放疗计划退行性迭代的研究OA

Study of Retrogressive Iteration of Cervical Cancer Radiotherapy Program Based on Monte Carlo Algorithm

中文摘要英文摘要

目的 研究Monaco治疗计划系统(Treatment Planning System,TPS)在宫颈癌放射治疗(简称"放疗")中退行性剂量迭代的触发因素以及高剂量迭代位置截断计算方案的可行性.方法 选取2023年6月1日至2024年4月1日间实施宫颈癌容积旋转调强治疗(Volumetric Modulated Arctherapy,VMAT)的30例患者为研究对象,处方剂量为45 Gy/25 F,每例患者设计2个全弧VMAT计划.在通量优化结束后,通过Progress Meter统计复杂度系数(Modulation Degree,MD)并依据差异率将实验病例分为High MD组与Low MD组,分析2组计划靶区(Planning Target Volume,PTV)的V45(器官接受至少45 Gy剂量的体积百分比,其他以此类推)通量优化与剂量优化结果间的差异率;对High MD组病例进一步研究,分析在靶区剂量的最高体积覆盖处进行截断的高位截断计划组(Plan HLC)与常规自动完成计划组Plan A的PTV的V45及主要危及器官(Organs At Risk,OARs)的剂量学、计划特征参数、计划剂量分布和计划验证结果间的差异.结果 对入组30例病例的MD值进行统计,High MD组(MD>3)有19例,占63.3%,Low MD组(MD<3)有11例,占37.7%.High MD组的PTV的V45通量优化结果与剂量优化结果差异率明显高于Low MD组;在High MD组的剂量迭代全过程中,PTV的V45达到峰值后可见明显的跌落.在对Plan A与Plan HLC实验病例的进一步分析中,靶区和主要OARs的剂量差异均有统计学意义[PTV的V45:t=3.116,P=0.013;小肠D0.03cc(0.03 cm3体积的最大剂量值):t=1.241,P=0.022;直肠V40:t=6.183,P=0.021;膀胱V40:t=3.174,P=0.032].剂量云图及剂量体积直方图的分析显示,2组差异趋势相近;剂量优化特征参数的统计结果表明,2组各项结果差异均有统计学意义(X线蒙特卡洛算法剂量优化时间:t=1.607、P=0.001;计划光子利用率:t=4.962、P=0.023;子野数量:t=2.512、P=0.022;机器跳数:t=8.201、P=0.001);2组计划的验证结果均符合临床要求,但Plan A组略高于Plan HLC组.结论 应用Monaco5.11 TPS进行优化宫颈癌放疗计划,MD值是触发退行性迭代的主要因素;在发生退行性迭代时的高剂量迭代位置截停计划符合临床实施条件,获取的Plan HLC计划可被用于放疗.

Objective To investigate the triggering factors of retrogressive dose iteration and the feasibility of the high-dose iteration position truncation calculation scheme of the Monaco treatment planning system(TPS)in radiotherapy for cervical cancer(referred to as"radiotherapy").Methods Thirty patients who underwent volumetric modulated arctherapy(VMAT)for cervical cancer from June 1,2023 to April 1,2024 were selected as the research subjects.The prescribed dose was 45 Gy/25 F,and two full-arc VMAT plans were designed for each patient.After the flux optimization was completed,the modulation degree(MD)was statistically analyzed through the Progress Meter,and the experimental cases were divided into the High MD group and the Low MD group based on the difference rate.The difference rate between the results of flux optimization and dose optimization of planning target volume(PTV)V45(the percentage of organs receiving at least 45 Gy dose,and other similar)in the two groups was analyzed;The patients in the High MD group(Plan HLC)were further studied to analyze the differences in the V45 of PTV and the dosimetry of major organs at risk(OARS),plan characteristic parameters,plan dose distribution and plan verification results between the high MD plan group and the conventional automatic completion plan group.Results The MD values of the 30 enrolled cases were statistically analyzed.There were 19 cases in the High MD group(MD>3),accounting for 63.3%,and 11 cases in the Low MD group(MD<3),accounting for 37.7%.The difference rate between the V45 flux optimization result and the dose optimization result of PTV in the High MD group was significantly higher than that in the Low MD group.During the entire dose iteration process of the High MD group,a significant drop was observed after the V45 of PTV reached its peak.In the further analysis of the experimental cases of Plan A and Plan HLC,the dose differences in the target area and the main OARs were statistically significant[V45 of PTV:t=3.116,P=0.013;Small intestine D0.03cc(the maximum dose value of 0.03 cm3 by volume):t=1.241,P=0.022;Rectal V40:t=6.183,P=0.021;Bladder V40:t=3.174,P=0.032].The analysis of the dose cloud graph and the dose-volume histogram showed that the difference trends of the two groups were similar.The statistical results of the characteristic parameters of dose optimization indicated that the differences in each result between the two groups were statistically significant(dose optimization time of X-ray Monte Carlo algorithm:t=1.607,P=0.001;Planned photon utilization rate:t=4.962,P=0.023;Number of subfields:t=2.512,P=0.022;Machine hop count:t=8.201,P=0.001).The verification results of both groups of plans met the clinical requirements,but the Plan A group was slightly higher than the Plan HLC group.Conclusion When using Monaco5.11 TPS to optimize the radiotherapy plan for cervical cancer,the MD value is the main factor triggering retrogressive iterations.The high-dose iterative position cut-offPlan when degenerative iterations occur meets the clinical implementation conditions,and the obtained Plan HLC plan can be used for radiotherapy.

陈宏林;陈晶晶;杨玉荟;苗慧

徐州市肿瘤医院 放疗科,江苏 徐州 221005邳州市人民医院 放疗科,江苏 徐州 221300徐州市肿瘤医院 放疗科,江苏 徐州 221005徐州市肿瘤医院 放疗科,江苏 徐州 221005

医药卫生

Monaco计划系统宫颈癌退行性迭代复杂度系数截断计算方案触发因素

Monaco planning systemcervical cancerretrogressive iterationmodulation degreetruncation calculation schemetrigger factor

《中国医疗设备》 2025 (7)

49-53,75,6

江苏省妇幼健康科研项目(F201950)徐州市卫生健康委科技项目(XWKYHT20220124)徐州市医药卫生面上项目(KC23230).

10.3969/j.issn.1674-1633.20241301

评论